We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Virology
-
1. Principles of virology
- Prof. Vincent Racaniello
-
2. The type I interferon system and viruses
- Dr. Adolfo Garcia-Sastre
-
3. Immune responses to viruses
- Prof. Paul Klenerman
- Emerging Pathogens
-
4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
5. Emerging respiratory viruses - discoveries between 2001 and 2005
- Prof. Ron Fouchier
-
6. Usage of vaccines and therapeutics in public health emergencies 1
- Prof. Gary Kobinger
-
7. Usage of vaccines and therapeutics in public health emergencies 2
- Prof. Gary Kobinger
-
8. Influenza virus pandemics: past and future
- Prof. Peter Palese
-
9. SARS-CoV and other emerging coronaviruses
- Prof. Ralph Baric
-
10. Dengue, Zika and Chickungunya viruses
- Prof. Ana Fernandez-Sesma
-
11. Paramyxoviruses: biology & pathogenesis
- Prof. Benhur Lee
-
12. Antiviral drugs (non-HIV)
- Prof. Megan Shaw
-
13. Biodefense challenges
- Dr. David Franz
- Important Pathogens and their Diseases
-
14. Natural history and pathogenesis of herpes virus infections
- Prof. Richard Whitley
-
15. Cytomegalovirus biology
- Prof. Domenico Tortorella
-
16. Hepatitis C virus: discovery, cure and protection
- Dr. Matthew Evans
-
17. Fundamentals of HIV biology
- Prof. Viviana Simon
-
18. Measles
- Prof. Diane E. Griffin
-
19. Monkeypox virus, vaccines, and therapeutics
- Prof. Rachel Roper
- New Frontiers
-
22. Viruses as anticancer weapons
- Prof. Roberto Cattaneo
-
23. Novel approaches to diagnosis of viral infections
- Prof. W. Ian Lipkin
-
24. The Global Virus Network: collaboration to address pandemic and regional threats
- Prof. Sten H. Vermund
-
25. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
- Archived Lectures *These may not cover the latest advances in the field
-
26. Principles of virology I
- Prof. Richard Condit
-
27. Principles of virology II
- Prof. Richard Condit
-
28. Complex DNA viruses: herpes virus
- Dr. John Blaho
-
29. Adeno-associated viruses (AAV)
- Prof. Kenneth Berns
-
30. Poxviruses: smallpox (variola), vaccinia and monkeypox
- Prof. Paula Traktman
-
31. Can HPV testing be the sole primary cervical screening modality?
- Prof. Jack Cuzick
-
32. From viruses to oncolytics
- Prof. Roberto Cattaneo
-
33. Non HIV antivirals
- Prof. Mary Klotman
-
34. Gastroenteritis viruses
- Prof. Mary Estes
-
35. Biodefense challenges
- Dr. Connie Schmaljohn
-
37. The past, present and future of vaccination
- Prof. Stanley Plotkin
-
38. Filoviruses
- Dr. Christopher Basler
-
39. Bunyaviruses
- Prof. Richard Elliott
-
40. The immunobiology of HIV
- Prof. Norman Letvin
-
41. Hepatitis C and HCV
- Prof. Stanley Lemon
Printable Handouts
Navigable Slide Index
- Introduction
- Bioterrorism/biowarfare
- CDC priority list of pathogens
- Viruses as BW agents
- Effective viral biothreats
- Biodefense vaccines
- Viral biothreats
- Smallpox description
- Smallpox historical BW threat
- Smallpox eradication
- Smallpox: the disease
- Smallpox: pros as a biothreat
- Smallpox: cons as a biothreat
- CDC vaccination plan for a BT event
- Monkeypox
- Smallpox: live Vaccinia virus vaccines
- Smallpox: MVA (modified Vaccinia virus Ankara)
- Smallpox: vaccines - risk vs. benefit
- Smallpox: therapeutics - cidofovir
- Smallpox: therapeutics - ST-246
- Smallpox - BW/BT considerations
- Equine encephalitis viruses
- VEEV, EEEV, WEEV
- U.S. cases of EEE
- U.S. cases of WEE
- Natural EEEV and WEEV cycles
- Natural VEEV cycles
- VEE outbreaks
- Existing Alphavirus vaccines
- Next generation vaccines
- VEEV, EEEV, WEEV - BW/BT considerations
- Viral hemorrhagic fevers
- Virus families causing VHF
- Viral hemorrhagic fever distribution
- Symptoms of VHF
- Treatment of VHF
- Filoviruses
- VHF as BW agents: Marburg and Ebola viruses
- Filoviruse distribution
- Filoviruse mortality
- Ebola hemorrhagic fever
- Marburg hemorrhagic fever
- Ebola hemorrhagic fever - disease symptoms
- Treatment of filovirus infections
- Stopping a filovirus epidemic
- Filovirus vaccine development
- FHF - BW/BT considerations
- Rift Valley fever virus
- RVF historically exclusive in Africa
- RVF in Saudi Arabia/Yemen 2002
- Correlation of rainfall to outbreaks of RVFV
- RVF ongoing outbreak - Kenya
- RVF - human disease
- Treatment of RVFV
- RVF - animal disease
- Rift valley fever vaccines (1)
- Rift valley fever vaccines (2)
- Rift valley fever vaccines (3)
- Rift Valley fever virus - BW/BT considerations
- Other challenges
- Conclusions
Topics Covered
- Viruses as bioterrorism or biowarfare threats
- Smallpox virus and monkeypox virus
- Equine encephalitis viruses: Venezuelan, eastern and western equine encephalitis viruses
- Ebola and Marburg viruses
- Rift Valley fever virus
- Genetically engineered viruses
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Schmaljohn, C. (2007, October 1). Biodefense challenges [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 5, 2024, from https://doi.org/10.69645/XERH2882.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Connie Schmaljohn has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.